Ann Dean, Ph.D.
Gene Regulation and Development Section, Laboratory of Cellular and Developmental Biology
Building 50, Room 3154
50 South Drive
Bethesda, MD 20814
The goal of these studies is to understand how cell-specific transcriptomes that define the differentiated tissues of an organism arise from the same genetic blueprint—the genome.
How complex organisms with diverse tissue and cell types can arise from the same genome is one of the most enduring and fascinating questions in biology. We study enhancers, which are cis-acting DNA sequences that increase the transcriptional output of genes and, in so doing, orchestrate the cell specific transcriptomes that underlie development and differentiation. We are interested in the mechanisms that underlie formation of long range interactions between distant enhancers and target genes, how they influence and are influenced by overall chromosome folding and how enhancers change gene expression programs. Our studies focus on the family of β-globin genes, and erythroid genes more broadly, as a model system.
We are defining a complex of proteins including Ldb1/Lmo2/Tal1/Gata1 that mediates long range enhancer activation of essentially all erythroid genes. We are investigating the proteins the Ldb1 complex partners with to function in chromatin looping. We are also interested in the functional impact on gene expression of overall chromosome folding in the nucleus, which is thought to depend on architectural factors such as CTCF and cohesin.
To study long range enhancer-gene interactions, epigenetic histone modification and transcription regulation in mammalian cells, we use biochemistry, molecular biology, genetics and genomics. We deploy ChIP, ChIP-seq, RNA-seq and Chromosome Conformation Capture (3C)-related approaches and bioinformatic analysis, as well as RNA and DNA fluorescent in situ hybridization. Our experimental systems include (1) human and mouse erythroid cell lines, primary cells and mouse ES cells, (2) human β-globin YAC transgenic mice, and (3) mice with alterations in endogenous loci that we have targeted through homologous recombination or CRISPR/Cas9 genome editing.
Applying our Research
Our studies have contributed to showing that modulation of long range enhancer looping can reactivate the silent γ-globin gene in adult erythroid cells, which is a novel approach to treatment of sickle cell disease and β-thalassemia. Moreover, a major appreciation over the last few years is that mutations in enhancers that affect long range gene activation play a major role in mis-regulation of genes and contribute to genetic diseases and cancers. Thus, understanding how chromatin interactions are regulated during development and differentiation may offer insights into the treatment of numerous diseases.
- Ph.D., The George Washington University, 1981
- B.A., Bucknell University, 1966
Ivaldi MS, Diaz LF, Chakalova L, Lee J, Krivega I, Dean A. Fetal γ-globin genes are regulated by the BGLT3 long non-coding RNA locus. Blood. 2018.
Lee J, Krivega I, Dale RK, Dean A. The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions. Cell Rep. 2017;19(12):2490-2502.
Krivega I, Dean A. LDB1-mediated enhancer looping can be established independent of mediator and cohesin. Nucleic Acids Res. 2017;45(14):8255-8268.
Krivega I, Dean A. Chromatin looping as a target for altering erythroid gene expression. Ann N Y Acad Sci. 2016;1368(1):31-9.
Krivega I, Dale RK, Dean A. Role of LDB1 in the transition from chromatin looping to transcription activation. Genes Dev. 2014;28(12):1278-90.
Related Scientific Focus Areas
Molecular Biology and Biochemistry
Genetics and Genomics
This page was last updated on September 19th, 2018